China Medical System (867.HK) New Drug Application of Diazepam Nasal Spray Accepted in China
2021-07-05 22:20

China Medical System Holdings Limited (the ¡°Company¡±, together with its subsidiaries, the ¡°Group¡±) is pleased to announce that on 05 July 2021, New Drug Application of Diazepam Nasal Spray (the ¡°Product¡±) has been accepted by the National Medical Products Administration of the People¡¯s Republic of China. The Product is an acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient¡¯s usual seizure pattern in people with epilepsy 6 years of age and older. The Product had been approved by the U.S. Food and Drug Administration.